FdaApplication
NDA 015539
Identifiers
- fda_app_no: NDA015539
Properties
| Property | Value |
|---|---|
| applicant_name | ALPHARMA US PHARMACEUTICALS DIVISION |
| application_type | NDA |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SERAX | OXAZEPAM | 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| SERAX | OXAZEPAM | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| SERAX | OXAZEPAM | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| SERAX | OXAZEPAM | 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
4 products